APO Research
Talk to an analyst

APO RESEARCH · REPORT

Furosemide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Furosemide Market Outlook and Growth Opportunities 2026

21 December 2025199 pages

Choose your research edition.

Industry ResearchFurosemide Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Furosemide Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Furosemide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Furosemide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Furosemide Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Furosemide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Furosemide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Furosemide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Furosemide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Furosemide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Furosemide market include Sun Pharm Inds, Sandoz, Sanofi Aventis, Mylan, West-Ward Pharms, US Pharm Holdings, Ivax Sub Teva Pharms, Hospira and Emcure Pharms, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Furosemide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Furosemide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Furosemide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Furosemide market size, projected growth trends, production technologies, key applications, and end-use industries.

Furosemide Segment by Company

Sun Pharm Inds

Sandoz

Sanofi Aventis

Mylan

West-Ward Pharms

US Pharm Holdings

Ivax Sub Teva Pharms

Hospira

Emcure Pharms

Furosemide Segment by Type

Injection

Solution

Tablet

Furosemide Segment by Application

Clinics

Hospital

Pharmacy

Others

Furosemide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Furosemide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Furosemide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Furosemide significant trends, drivers, influence factors in global and regions.

6. To analyze Furosemide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Furosemide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Furosemide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Furosemide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Furosemide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Furosemide industry.

Chapter 3: Detailed analysis of Furosemide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Furosemide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Furosemide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Furosemide Industry Trends Table 2. Furosemide Industry Drivers Table 3. Furosemide Industry Opportunities and Challenges Table 4. Furosemide Industry Restraints Table 5. Global Furosemide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Furosemide Revenue Share by Company (2021-2026) Table 7. Global Furosemide Sales Volume by Company (tons) & (2021-2026) Table 8. Global Furosemide Sales Volume Share by Company (2021-2026) Table 9. Global Furosemide Average Price (US$/kg) of Company (2021-2026) Table 10. Global Furosemide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Furosemide Key Company Manufacturing Base & Headquarters Table 12. Global Furosemide Company, Product Type & Application Table 13. Global Furosemide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Furosemide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Solution Table 19. Significant Companies of Tablet Table 20. Global Furosemide Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 21. Global Furosemide Sales Volume by Type (2021-2026) & (tons) Table 22. Global Furosemide Sales Volume by Type (2027-2032) & (tons) Table 23. Global Furosemide Sales Volume Share by Type (2021-2026) Table 24. Global Furosemide Sales Volume Share by Type (2027-2032) Table 25. Global Furosemide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Furosemide Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Furosemide Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Furosemide Sales Value Share by Type (2021-2026) Table 29. Global Furosemide Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Clinics Table 31. Significant Companies of Hospital Table 32. Significant Companies of Pharmacy Table 33. Significant Companies of Others Table 34. Global Furosemide Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 35. Global Furosemide Sales Volume by Application (2021-2026) & (tons) Table 36. Global Furosemide Sales Volume by Application (2027-2032) & (tons) Table 37. Global Furosemide Sales Volume Share by Application (2021-2026) Table 38. Global Furosemide Sales Volume Share by Application (2027-2032) Table 39. Global Furosemide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Furosemide Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Furosemide Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Furosemide Sales Value Share by Application (2021-2026) Table 43. Global Furosemide Sales Value Share by Application (2027-2032) Table 44. Global Furosemide Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 45. Global Furosemide Sales by Region (2021-2026) & (tons) Table 46. Global Furosemide Sales Market Share by Region (2021-2026) Table 47. Global Furosemide Sales by Region (2027-2032) & (tons) Table 48. Global Furosemide Sales Market Share by Region (2027-2032) Table 49. Global Furosemide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Furosemide Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Furosemide Sales Value Share by Region (2021-2026) Table 52. Global Furosemide Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Furosemide Sales Value Share by Region (2027-2032) Table 54. Global Furosemide Market Average Price (US$/kg) by Region (2021-2026) Table 55. Global Furosemide Market Average Price (US$/kg) by Region (2027-2032) Table 56. Global Furosemide Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 57. Global Furosemide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Furosemide Sales by Country (2021-2026) & (tons) Table 59. Global Furosemide Sales Market Share by Country (2021-2026) Table 60. Global Furosemide Sales by Country (2027-2032) & (tons) Table 61. Global Furosemide Sales Market Share by Country (2027-2032) Table 62. Global Furosemide Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Furosemide Sales Value Market Share by Country (2021-2026) Table 64. Global Furosemide Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Furosemide Sales Value Market Share by Country (2027-2032) Table 66. Sun Pharm Inds Company Information Table 67. Sun Pharm Inds Business Overview Table 68. Sun Pharm Inds Furosemide Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 69. Sun Pharm Inds Furosemide Product Portfolio Table 70. Sun Pharm Inds Recent Development Table 71. Sandoz Company Information Table 72. Sandoz Business Overview Table 73. Sandoz Furosemide Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Sandoz Furosemide Product Portfolio Table 75. Sandoz Recent Development Table 76. Sanofi Aventis Company Information Table 77. Sanofi Aventis Business Overview Table 78. Sanofi Aventis Furosemide Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Sanofi Aventis Furosemide Product Portfolio Table 80. Sanofi Aventis Recent Development Table 81. Mylan Company Information Table 82. Mylan Business Overview Table 83. Mylan Furosemide Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Mylan Furosemide Product Portfolio Table 85. Mylan Recent Development Table 86. West-Ward Pharms Company Information Table 87. West-Ward Pharms Business Overview Table 88. West-Ward Pharms Furosemide Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. West-Ward Pharms Furosemide Product Portfolio Table 90. West-Ward Pharms Recent Development Table 91. US Pharm Holdings Company Information Table 92. US Pharm Holdings Business Overview Table 93. US Pharm Holdings Furosemide Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. US Pharm Holdings Furosemide Product Portfolio Table 95. US Pharm Holdings Recent Development Table 96. Ivax Sub Teva Pharms Company Information Table 97. Ivax Sub Teva Pharms Business Overview Table 98. Ivax Sub Teva Pharms Furosemide Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. Ivax Sub Teva Pharms Furosemide Product Portfolio Table 100. Ivax Sub Teva Pharms Recent Development Table 101. Hospira Company Information Table 102. Hospira Business Overview Table 103. Hospira Furosemide Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. Hospira Furosemide Product Portfolio Table 105. Hospira Recent Development Table 106. Emcure Pharms Company Information Table 107. Emcure Pharms Business Overview Table 108. Emcure Pharms Furosemide Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 109. Emcure Pharms Furosemide Product Portfolio Table 110. Emcure Pharms Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Furosemide Distributors List Table 114. Furosemide Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Furosemide Product Image Figure 2. Global Furosemide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Furosemide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Furosemide Sales (2021-2032) & (tons) Figure 5. Global Furosemide Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Furosemide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Solution Image Figure 11. Tablet Image Figure 12. Global Furosemide Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 13. Global Furosemide Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Furosemide Sales Volume Share by Type (2021-2032) Figure 15. Global Furosemide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Furosemide Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Furosemide Sales Value Share by Type (2021-2032) Figure 18. Clinics Image Figure 19. Hospital Image Figure 20. Pharmacy Image Figure 21. Others Image Figure 22. Global Furosemide Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 23. Global Furosemide Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Furosemide Sales Volume Share by Application (2021-2032) Figure 25. Global Furosemide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Furosemide Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Furosemide Sales Value Share by Application (2021-2032) Figure 28. Global Furosemide Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 29. Global Furosemide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Furosemide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Furosemide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Furosemide Sales Value (2021-2032) & (US$ Million) Figure 33. North America Furosemide Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Furosemide Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Furosemide Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Furosemide Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Furosemide Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Furosemide Sales Value (2021-2032) & (US$ Million) Figure 39. South America Furosemide Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Furosemide Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Furosemide Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Furosemide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Furosemide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Furosemide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Furosemide Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Furosemide Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Solution
  • Tablet
Applications
  • Clinics
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Sun Pharm Inds
  • Sandoz
  • Sanofi Aventis
  • Mylan
  • West-Ward Pharms
  • US Pharm Holdings
  • Ivax Sub Teva Pharms
  • Hospira
  • Emcure Pharms

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Furosemide Sales Value (2021-2032)
  4. 1.2.2 Global Furosemide Sales Volume (2021-2032)
  5. 1.2.3 Global Furosemide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Furosemide Market Dynamics
  1. 2.1 Furosemide Industry Trends
  2. 2.2 Furosemide Industry Drivers
  3. 2.3 Furosemide Industry Opportunities and Challenges
  4. 2.4 Furosemide Industry Restraints
3 Furosemide Market by Company
  1. 3.1 Global Furosemide Company Revenue Ranking in 2025
  2. 3.2 Global Furosemide Revenue by Company (2021-2026)
  3. 3.3 Global Furosemide Sales Volume by Company (2021-2026)
  4. 3.4 Global Furosemide Average Price by Company (2021-2026)
  5. 3.5 Global Furosemide Company Ranking (2024-2026)
  6. 3.6 Global Furosemide Company Manufacturing Base and Headquarters
  7. 3.7 Global Furosemide Company Product Type and Application
  8. 3.8 Global Furosemide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Furosemide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Furosemide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Furosemide Market by Type
  1. 4.1 Furosemide Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Solution
  4. 4.1.3 Tablet
  5. 4.2 Global Furosemide Sales Volume by Type
  6. 4.2.1 Global Furosemide Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Furosemide Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Furosemide Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Furosemide Sales Value by Type
  10. 4.3.1 Global Furosemide Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Furosemide Sales Value by Type (2021-2032)
  12. 4.3.3 Global Furosemide Sales Value Share by Type (2021-2032)
5 Furosemide Market by Application
  1. 5.1 Furosemide Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Furosemide Sales Volume by Application
  7. 5.2.1 Global Furosemide Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Furosemide Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Furosemide Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Furosemide Sales Value by Application
  11. 5.3.1 Global Furosemide Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Furosemide Sales Value by Application (2021-2032)
  13. 5.3.3 Global Furosemide Sales Value Share by Application (2021-2032)
6 Furosemide Regional Sales and Value Analysis
  1. 6.1 Global Furosemide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Furosemide Sales by Region (2021-2032)
  3. 6.2.1 Global Furosemide Sales by Region: 2021-2026
  4. 6.2.2 Global Furosemide Sales by Region (2027-2032)
  5. 6.3 Global Furosemide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Furosemide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Furosemide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Furosemide Sales Value by Region (2027-2032)
  9. 6.5 Global Furosemide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Furosemide Sales Value (2021-2032)
  12. 6.6.2 North America Furosemide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Furosemide Sales Value (2021-2032)
  15. 6.7.2 Europe Furosemide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Furosemide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Furosemide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Furosemide Sales Value (2021-2032)
  21. 6.9.2 South America Furosemide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Furosemide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Furosemide Sales Value Share by Country, 2025 VS 2032
7 Furosemide Country-level Sales and Value Analysis
  1. 7.1 Global Furosemide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Furosemide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Furosemide Sales by Country (2021-2032)
  4. 7.3.1 Global Furosemide Sales by Country (2021-2026)
  5. 7.3.2 Global Furosemide Sales by Country (2027-2032)
  6. 7.4 Global Furosemide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Furosemide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Furosemide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Furosemide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Furosemide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Furosemide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Furosemide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Furosemide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Furosemide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Furosemide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Furosemide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Furosemide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Furosemide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Furosemide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Furosemide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Furosemide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Furosemide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Furosemide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Furosemide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Furosemide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Furosemide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Furosemide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Furosemide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Furosemide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Furosemide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Furosemide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Furosemide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Furosemide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Furosemide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Furosemide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Furosemide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Furosemide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Furosemide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Furosemide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Furosemide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Furosemide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Furosemide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Furosemide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Furosemide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Furosemide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Furosemide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Furosemide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Furosemide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Furosemide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Furosemide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Furosemide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Furosemide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Furosemide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Furosemide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Furosemide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Furosemide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Furosemide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Furosemide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Furosemide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Furosemide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Furosemide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Furosemide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Furosemide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Furosemide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Furosemide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Furosemide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Furosemide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Furosemide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Furosemide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Furosemide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Furosemide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Furosemide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Furosemide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Furosemide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Furosemide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Furosemide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Furosemide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Furosemide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Furosemide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Furosemide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Furosemide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Furosemide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Furosemide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Furosemide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Furosemide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Furosemide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Furosemide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Furosemide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Furosemide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Furosemide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Furosemide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Furosemide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharm Inds
  2. 8.1.1 Sun Pharm Inds Company Information
  3. 8.1.2 Sun Pharm Inds Business Overview
  4. 8.1.3 Sun Pharm Inds Furosemide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharm Inds Furosemide Product Portfolio
  6. 8.1.5 Sun Pharm Inds Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Furosemide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Furosemide Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Sanofi Aventis
  14. 8.3.1 Sanofi Aventis Company Information
  15. 8.3.2 Sanofi Aventis Business Overview
  16. 8.3.3 Sanofi Aventis Furosemide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Aventis Furosemide Product Portfolio
  18. 8.3.5 Sanofi Aventis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Furosemide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Furosemide Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 West-Ward Pharms
  26. 8.5.1 West-Ward Pharms Company Information
  27. 8.5.2 West-Ward Pharms Business Overview
  28. 8.5.3 West-Ward Pharms Furosemide Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 West-Ward Pharms Furosemide Product Portfolio
  30. 8.5.5 West-Ward Pharms Recent Developments
  31. 8.6 US Pharm Holdings
  32. 8.6.1 US Pharm Holdings Company Information
  33. 8.6.2 US Pharm Holdings Business Overview
  34. 8.6.3 US Pharm Holdings Furosemide Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 US Pharm Holdings Furosemide Product Portfolio
  36. 8.6.5 US Pharm Holdings Recent Developments
  37. 8.7 Ivax Sub Teva Pharms
  38. 8.7.1 Ivax Sub Teva Pharms Company Information
  39. 8.7.2 Ivax Sub Teva Pharms Business Overview
  40. 8.7.3 Ivax Sub Teva Pharms Furosemide Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Ivax Sub Teva Pharms Furosemide Product Portfolio
  42. 8.7.5 Ivax Sub Teva Pharms Recent Developments
  43. 8.8 Hospira
  44. 8.8.1 Hospira Company Information
  45. 8.8.2 Hospira Business Overview
  46. 8.8.3 Hospira Furosemide Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hospira Furosemide Product Portfolio
  48. 8.8.5 Hospira Recent Developments
  49. 8.9 Emcure Pharms
  50. 8.9.1 Emcure Pharms Company Information
  51. 8.9.2 Emcure Pharms Business Overview
  52. 8.9.3 Emcure Pharms Furosemide Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Emcure Pharms Furosemide Product Portfolio
  54. 8.9.5 Emcure Pharms Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Furosemide Value Chain Analysis
  2. 9.1.1 Furosemide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Furosemide Sales Mode & Process
  6. 9.2 Furosemide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Furosemide Distributors
  9. 9.2.3 Furosemide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst